What symptoms can occur in newborns exposed to olanzapine during the third trimester of pregnancy?

Newborns exposed to olanzapine during the third trimester may develop extrapyramidal and/or withdrawal symptoms, including agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress or feeding disorder, which may vary in severity and duration after delivery and require careful monitoring.